{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T00:04:02Z","timestamp":1793232242101,"version":"4.5.0"},"reference-count":98,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,4,28]],"date-time":"2025-04-28T00:00:00Z","timestamp":1745798400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100010842","name":"Temple University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010842","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Psychiatry"],"abstract":"<jats:p>The medical and public health communities are divided around the use of benzodiazepine (\u201cbenzo\u201d) pharmacotherapy for anxiety disorders. Recent years have seen increased attention to benzo overprescription and its risks, leading to a pervasive emphasis on deprescribing. Some have resisted this trend, arguing that the balance of evidence supports the safety and efficacy of benzo pharmacotherapy for both short-term and long-term treatment of anxiety disorders. Given that rising rates of anxiety disorders and benzo misuse are both serious public health concerns, there is an urgent need for comprehensive evidence-based best practices for the prescription of benzos for anxiety. At present, however, major scientific gaps make it impossible to formulate such guidance. Most concerning is the lack of research into as-needed and intermittent prescription and use, which are both what benzos are best suited for, and likely, how they are most commonly administered. Further research into the safety and efficacy of both long-term daily and intermittent, as-needed benzo prescription and use are badly needed. But a roundly \u201canti-benzo\u201d sentiment may be causing problematic underprescription of benzos, particularly when superior alternatives like cognitive-behavioral therapy are not widely available.<\/jats:p>","DOI":"10.3389\/fpsyt.2025.1569416","type":"journal-article","created":{"date-parts":[[2025,4,28]],"date-time":"2025-04-28T05:29:36Z","timestamp":1745818176000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":5,"title":["Benzos (as) needed: research into as-needed and intermittent benzodiazepines for anxiety is required for comprehensive best prescribing practices"],"prefix":"10.3389","volume":"16","author":[{"given":"Arthur","family":"Krieger","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,4,28]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1016\/j.janxdis.2011.01.002","article-title":"The discovery of chlordiazepoxide and the clinical introduction of benzodiazepines: Half a century of anxiolytic drugs","volume":"25","author":"L\u00f3pez-Munoz","year":"2011","journal-title":"J\u00a0Anxiety Disord"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1016\/0163-8343(91)90122-D","article-title":"Regulation of benzodiazepine prescribing practices: Clinical implications","volume":"13","author":"Schwartz","year":"1991","journal-title":"Gen Hosp Psychiatry"},{"key":"B3","doi-asserted-by":"publisher","first-page":"454","DOI":"10.5694\/j.1326-5377.1994.tb127540.x","article-title":"Benzodiazepine use\u2014continuing to fall","volume":"161","author":"Mant","year":"1994","journal-title":"Med J Aust"},{"key":"B4","article-title":"An analysis of the efficacy of diazepam","volume":"3","author":"Feldman","year":"1962","journal-title":"J Neuropsychiatry"},{"key":"B5","article-title":"Clinical assessment of the safety and efficacy of lorazepam, a new benzodiazepine derivative, in the treatment of anxiety","author":"Pinosky","year":"1978","journal-title":"J Clin Psychiatry 39(10 Sec. 2)"},{"key":"B6","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/BF00426784","article-title":"Use of antianxiety agents in anxious outpatients","volume":"58","author":"Rickels","year":"1978","journal-title":"Psychopharmacology"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1176\/ajp.136.2.196","article-title":"Comparative efficacy of tofisopam and placebo","volume":"136","author":"Goldberg","year":"1979","journal-title":"Am J Psychiatry"},{"key":"B8","first-page":"4","article-title":"High-potency benzodiazepines for short-term management of panic disorder: the U.S","volume":"51","author":"Tesar","year":"1990","journal-title":"experience. J Clin Psychiatry"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1002\/hup.510","article-title":"Efficacy of diazepam as an anti-anxiety agent: meta-analysis of double-blind, randomized controlled trials carried out in Japan","volume":"18","author":"Inada","year":"2003","journal-title":"Hum Psychopharmacol"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMp1715050","article-title":"Our other prescription drug problem","volume":"378","author":"Lembke","year":"2018","journal-title":"New Engl J Med"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1097\/01.NPR.0000733684.24949.19","article-title":"Best practices in benzodiazepine prescribing and management in primary care","volume":"46","author":"Champion","year":"2021","journal-title":"Nurse Practitioner"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.12788\/jfp.0381","article-title":"Benzodiazepine and Z-hypnotic stewardship","volume":"71","author":"Wright","year":"2022","journal-title":"J Family Pract"},{"key":"B13","unstructured":"Generalized anxiety disorder and panic disorder in adults: management (CG113)\n          \n          \n          \n          2011"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1186\/1471-244X-14-S1-S1","article-title":"Canadian clinical practice guidelines for the management of anxiety, posttraumatic stress and obsessive-compulsive disorder","volume":"14","author":"Katzman","year":"2014","journal-title":"BMC Psychiatry"},{"key":"B15","unstructured":"FDA Drug Safety Communication: FDA warns about serious risks and death when combining opioid pain or cough medicines with benzodiazepines; requires its strongest warning\n          \n          \n          \n          2017"},{"key":"B16","unstructured":"FDA requiring Boxed Warning updated to improve safe use of benzodiazepine drug class; Includes potential for abuse, addiction, and other serious risks\n          \n          \n          \n          2020"},{"key":"B17","unstructured":"Professional Practices Guideline 5: Guidance for the use of benzodiazepines in psychiatric practice\n          \n          \n          \n          2019"},{"key":"B18","unstructured":"Mental Health Gap Action Programme (mhGAP) guideline for mental, neurological and substance use disorders (Third edition)\n          \n          \n          \n          2023"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1016\/j.eclinm.2024.102507","article-title":"Prescribing and deprescribing guidance for benzodiazepine and benzodiazepine receptor agonist use in adults with depression, anxiety, and insomnia: an international scoping review","volume":"70","author":"Brandt","year":"2024","journal-title":"Lancet"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1007\/s00228-017-2257-8","article-title":"A systematic review of interventions to deprescribe benzodiazepines and other hypnotics among older people","volume":"73","author":"Reeve","year":"2017","journal-title":"Eur J Clin Pharmacol"},{"key":"B21","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1111\/add.15997","article-title":"Feasibility and effectiveness of deprescribing benzodiazepines and Z-drugs: systematic review and meta-analysis","volume":"118","author":"Soni","year":"2023","journal-title":"Addiction"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ps.202100617","article-title":"Long-term benzodiazepine use and discontinuation among patients in the U.S. Veterans Health Administration","volume":"73","author":"Timko","year":"2022","journal-title":"Psychiatr Serv"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1111\/jgs.18728","article-title":"Evaluation of a benzodiazepine deprescribing quality improvement initiative for older adults in primary care","volume":"72","author":"Chae","year":"2024","journal-title":"J Am Geriatrics Soc"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1093\/fampra\/cmac049","article-title":"Benzodiazepine use: cross-national perspectives","volume":"40","author":"Modesto-Lowe","year":"2023","journal-title":"Family Pract"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2023-080109","article-title":"Implementation of an intervention aimed at deprescribing benzodiazepines in a large US healthcare system using patient education materials: a pre\/post-observational study with a control group","volume":"14","author":"Le","year":"2024","journal-title":"BMJ Open"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1159\/000524400","article-title":"Benzodiazepines remain important therapeutic options in psychiatric practice","volume":"91","author":"Dubrovsky","year":"2022","journal-title":"Psychother Psychosomatics"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ps.202100671","article-title":"Walking the benzodiazepine high wire","volume":"74","author":"Kroenke","year":"2023","journal-title":"Psychiatr Serv"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.23com14959","article-title":"Resolving the paradox of long-term benzodiazepine treatment: Towards evidence-based practice guidelines","volume":"84","author":"Silberman","year":"2023","journal-title":"J Clin Psychiatry"},{"key":"B29","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/0163-8343(91)90122-D","article-title":"Concerns about long-term benzodiazepine treatment and the state of the evidence: A reply to Sigler et\u00a0al","volume":"85","author":"Silberman","year":"2024","journal-title":"J Clin Psychiatry"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.20240030","article-title":"Setting the record straight on long-term use, dose escalation, and potential misuse of prescription benzodiazepines","volume":"181","author":"Soumerai","year":"2024","journal-title":"Am J Psychiatry"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2702.2007.02236.x","article-title":"A best-evidence synthesis review of the administration of psychotropic pro re nata (PRN) medication in in-patient mental health settings","volume":"17","author":"Baker","year":"2008","journal-title":"J Clin Nurs"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1097\/YIC.0b013e328362db99","article-title":"Absence of evidence that the pro re nata regimen confers benefit: a review of the studies","volume":"28","author":"Yoshida","year":"2013","journal-title":"Int Clin Psychopharmacol"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2850.2012.01960.x","article-title":"Resistance to changing practice from pro re nata prescriptions to patient group directions in acute mental health settings","volume":"20","author":"Price","year":"2013","journal-title":"J Psychiatr Ment Health Nurs"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1111\/inm.12265","article-title":"Descriptive analysis of pro re nata medication use at a Canadian psychiatric hospital","volume":"26","author":"Martin","year":"2017","journal-title":"Int J Ment Health Nurs"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.3928\/02793695-20191218-07","article-title":"Let\u2019s talk about benzodiazepine use: Inpatient psychiatric nurses initiating the conversation","volume":"58","author":"Delaney","year":"2020","journal-title":"J Psychosocial Nurs"},{"key":"B36","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1177\/1060028022111781","article-title":"Use of a novel standardized administration protocol reduces agitation pro re nata (PRN) medication requirements: The Birmingham Agitation Management (BAM) initiative","volume":"57","author":"Burk","year":"2023","journal-title":"Ann Pharmacotherapy"},{"key":"B37","doi-asserted-by":"publisher","first-page":"59","DOI":"10.2174\/1381612023396744","article-title":"As-needed use of benzodiazepines in managing clinical anxiety: incidence and implications","volume":"8","author":"Westra","year":"2002","journal-title":"Curr Pharmaceutical Design"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.3109\/08039488.2013.775342","article-title":"Socio-demographic, lifestyle and psychological predictors of benzodiazepine and z-hypnotic use patterns","volume":"68","author":"Nordfj\u00e6rn","year":"2014","journal-title":"Nordic J Psychiatry"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2018.e00688","article-title":"Patterns of benzodiazepines use in primary care adults with anxiety disorders","volume":"4","author":"Bernard","year":"2018","journal-title":"Heliyon"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1177\/02698811211069096","article-title":"Comparative safety of chronic versus intermittent benzodiazepine prescribing in older adults: A population-based cohort study","volume":"36","author":"Davies","year":"2022","journal-title":"J Psychopharmacol"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2018.7399","article-title":"Patterns in outpatient benzodiazepine prescribing in the United States","volume":"2","author":"Agarwal","year":"2019","journal-title":"JAMA Network Open"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1001\/jamapsychiatry.2014.1763","article-title":"Benzodiazepine use in the United States","volume":"72","author":"Olfson","year":"2015","journal-title":"JAMA Psychiatry"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.2105\/AJPH.2016.303061","article-title":"Increasing benzodiazepine prescription and overdose mortality in the United States 1996-2013","volume":"106","author":"Bachhuber","year":"2016","journal-title":"Am J Public Health"},{"key":"B44","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s43045-023-00315-3","article-title":"Epidemiology of anxiety disorders: global burden and sociodemographic associations","volume":"30","author":"Javaid","year":"2023","journal-title":"Middle East Curr Psychiatry"},{"key":"B45","doi-asserted-by":"publisher","first-page":"CS353885","DOI":"10.15620\/cdc\/64018","article-title":"Symptoms of anxiety and depression among adults: United States 2019 and 2022","volume":"213","author":"Terlizzi","year":"2024","journal-title":"Natl Health Stat Rep"},{"key":"B46","unstructured":"Youth Mental Health: The Numbers\n          \n          \n          \n          2024"},{"key":"B47","doi-asserted-by":"publisher","first-page":"899","DOI":"10.1007\/s10597-018-0252-x","article-title":"A preliminary exploration of the barriers to delivering (and receiving) exposure-based cognitive behavioral therapy for anxiety disorders in adult community mental health settings","volume":"54","author":"Wolitzki-Taylor","year":"2018","journal-title":"Community Ment Health J"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0264368","article-title":"Strategies to improve access to cognitive behavioral therapies for anxiety disorders: A scoping review","volume":"17","author":"Carrier","year":"2022","journal-title":"PLoS One"},{"key":"B49","unstructured":"Lack of access to evidence-based mental health care poses grave threat\n          \n          \n            \n              Resnick\n              J\n            \n          \n          American Medical Association\n          \n          2022"},{"key":"B50","article-title":"Mental health care is in high demand. Psychologists are leveraging tech and peers to meet the need","volume":"55","author":"Stringer","year":"2024","journal-title":"Monitor Psychol"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.1097\/PRA.0000000000000114","article-title":"A way of conceptualizing benzodiazepines to guide clinical use","volume":"21","author":"Preskorn","year":"2015","journal-title":"J Psychiatr Pract"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.1111\/j.1360-0443.1981.tb00218.x","article-title":"Benzodiazepine dependence","volume":"76","author":"Petursson","year":"1981","journal-title":"Br J Addict"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.1001\/jamapsychiatry.2022.1150","article-title":"Complex persistent benzodiazepine dependence\u2013when benzodiazepine deprescribing goes awry","volume":"79","author":"Peng","year":"2022","journal-title":"JAMA Psychiatry"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.1016\/j.neubiorev.2015.06.012","article-title":"How fast and how often: The pharmacokinetics of drug use are decisive in addiction","volume":"56","author":"Allain","year":"2015","journal-title":"Neurosci Biobehavioral Rev"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.1152\/physrev.00014.2018","article-title":"The neuroscience of drug reward and addiction","volume":"99","author":"Volkow","year":"2019","journal-title":"Physiol Rev"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0285584","article-title":"Long-term consequences of benzodiazepine-induced neurological dysfunction: A survey","volume":"18","author":"Ritvo","year":"2023","journal-title":"PLoS One"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.7556\/jaoa.2019.055","article-title":"Complicated withdrawal phenomena during benzodiazepine cessation in older adults","volume":"119","author":"Reeves","year":"2019","journal-title":"J Am Osteopathic Assoc"},{"key":"B58","unstructured":"Drug Scheduling\n          \n          \n          \n          2018"},{"key":"B59","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/B978-0-444-53817-8.00005-0","article-title":"Effects of the use of hypnotics on cognition","volume":"190","author":"Vermeeren","year":"2011","journal-title":"Prog Brain Res"},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbspin.2019.11.003","article-title":"Association between benzodiazepines use and risk of hip fracture in elderly people: a meta-analysis of observational studies","volume":"87","author":"Poly","year":"2020","journal-title":"Joint Bone Spine"},{"key":"B61","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0127836","article-title":"Associations between benzodiazepine use and dementia: a meta-analysis","volume":"10","author":"Zhong","year":"2015","journal-title":"PLoS One"},{"key":"B62","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1176\/appi.ajp.2019.19030315","article-title":"Associations of benzodiazepines, Z-drugs, and other anxiolytics with subsequent dementia in patients with affective disorders: A nationwide cohort and nested case-control study","volume":"177","author":"Osler","year":"2020","journal-title":"Am J Psychiatry"},{"key":"B63","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.2020.20040375","article-title":"Do benzodiazepines cause alzheimer\u2019s disease","volume":"177","author":"Salzman","year":"2020","journal-title":"Am J Psychiatry"},{"key":"B64","doi-asserted-by":"publisher","DOI":"10.1017\/S0033291700003214","article-title":"Computed axial brain tomography in long-term benzodiazepine users","volume":"14","author":"Lader","year":"1984","journal-title":"psychol Med"},{"key":"B65","doi-asserted-by":"publisher","DOI":"10.1017\/S0033291700000660","article-title":"Enlargement of cerebrospinal fluid spaces in long-term benzodiazepine abusers","volume":"17","author":"Schmauss","year":"1987","journal-title":"psychol Med"},{"key":"B66","doi-asserted-by":"publisher","DOI":"10.1111\/j.1360-0443.1989.tb00612.x","article-title":"Dependence on sedative-hypnotics: neuropsychological impairment, field dependence and clinical course in a 5-year follow-up study","volume":"84","author":"Bergman","year":"1989","journal-title":"Br J Addict"},{"key":"B67","doi-asserted-by":"publisher","DOI":"10.1017\/S0033291700026003","article-title":"Computerized axial tomographic studies following long-term use of benzodiazepines","volume":"17","author":"Perera","year":"1987","journal-title":"psychol Med"},{"key":"B68","doi-asserted-by":"publisher","DOI":"10.1016\/0165-1781(93)90037-H","article-title":"Computed axial brain tomograms in long-term benzodiazepine users","volume":"48","author":"Moodley","year":"1993","journal-title":"Psychiatry Res"},{"key":"B69","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1097\/00004714-200002000-00002","article-title":"Long-term benzodiazepine therapy does not result in brain abnormalities","volume":"20","author":"Busto","year":"2000","journal-title":"J Clin Psychopharmacol"},{"key":"B70","doi-asserted-by":"publisher","first-page":"CD006815","DOI":"10.1002\/14651858","article-title":"Hydroxyzine for generalized anxiety disorder","volume":"12","author":"Guiana","year":"2010","journal-title":"Cochrane Database Systematic Rev"},{"key":"B71","doi-asserted-by":"publisher","DOI":"10.1007\/BF03009311","article-title":"Comparison between alprazolam and hydroxyzine for oral premedication","volume":"40","author":"Franssen","year":"1993","journal-title":"Can J Anaesth"},{"key":"B72","doi-asserted-by":"publisher","DOI":"10.1007\/BF00626365","article-title":"Peripheral antihistamine and central sedative effects of single and continuous oral doses of cetirizine and hydroxyzine","volume":"41","author":"Levander","year":"1991","journal-title":"Eur J Clin Pharmacol"},{"key":"B73","volume-title":"The Benzodiazepines: Use, Overuse, Misuse, Abuse","author":"Marks","year":"1985"},{"key":"B74","article-title":"Policy concerns: New York State\u2019s experience with triplicate prescriptions","volume-title":"Balancing the Response to Prescription Drug Abuse: Report of a National Symposium on Medicine and Public Policy","author":"Farnsworth","year":"1990"},{"key":"B75","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(10)61462-6","article-title":"Drug harms in the UK: a multicriteria decision analysis","volume":"376","author":"Nutt","year":"2010","journal-title":"Lancet"},{"key":"B76","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugpo.2021.103512","article-title":"From the clinic to the street: the changing role of benzodiazepines in the Scottish overdose epidemic","volume":"100","author":"McAuley","year":"2022","journal-title":"Int J Drug Policy"},{"key":"B77","doi-asserted-by":"publisher","DOI":"10.1055\/s-2007-979558","article-title":"Long-term use of benzodiazepines: tolerance, dependence and clinical problems in anxiety and mood disorders","volume":"29","author":"Michaelini","year":"1996","journal-title":"Pharmacopsychiatry"},{"key":"B78","doi-asserted-by":"publisher","DOI":"10.1007\/s40261-016-0397-9","article-title":"Benzodiazepine use, misuse, and harm at the population level in Canada: A comprehensive narrative review of data and developments since 1995","volume":"36","author":"Murphy","year":"2016","journal-title":"Clin Drug Invest"},{"key":"B79","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/j.drugalcdep.2019.02.033","article-title":"The epidemiology of benzodiazepine misuse: a systematic review","volume":"200","author":"Votaw","year":"2019","journal-title":"Drug Alcohol Depend"},{"key":"B80","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/jcm7020017","article-title":"Benzodiazepines I: upping the care on downers: the evidence of risks, benefits and alternatives","volume":"7","author":"Guina","year":"2018","journal-title":"J Clin Med"},{"key":"B81","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1176\/appi.ps.201800321","article-title":"Benzodiazepine use and misuse among adults in the United States","volume":"70","author":"Maust","year":"2019","journal-title":"Psychiatr Serv"},{"key":"B82","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.20230075","article-title":"Long-term use of benzodiazepines and benzodiazepine-related drugs: a register-based Danish cohort study on determinants and risk of dose escalation","volume":"181","author":"Rosenqvist","year":"2024","journal-title":"Am J Psychiatry"},{"key":"B83","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ps.54.7.1006","article-title":"Lack of relationship between long-term use of benzodiazepines and escalation to high dosages","volume":"54","author":"Soumerai","year":"2003","journal-title":"Psychiatr Serv"},{"key":"B84","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2013-003296","article-title":"A 3-year survey quantifying the risk of dose escalation of benzodiazepines and congeners to identify risk factors to aid doctors to more rationale prescribing","volume":"3","author":"Tvete","year":"2013","journal-title":"BMJ Open"},{"key":"B85","doi-asserted-by":"publisher","DOI":"10.1097\/01.jcp.0000185345.77966.7f","article-title":"How safe is long-term benzodiazepine pharmacotherapy","volume":"25","author":"Schwartz","year":"2005","journal-title":"J Clin Psychopharmacol"},{"key":"B86","doi-asserted-by":"publisher","DOI":"10.1080\/15622975.2018.1500031","article-title":"Benzodiazepines in anxiety disorders: reassessment of usefulness and safety","volume":"20","author":"Rickels","year":"2019","journal-title":"World J Biol Psychiatry"},{"key":"B87","doi-asserted-by":"publisher","DOI":"10.1177\/104012372003200214","article-title":"Systematic review of benzodiazepines for anxiety disorders in late life","volume":"32","author":"Gupta","year":"2020","journal-title":"Ann Clin Psychiatry"},{"key":"B88","doi-asserted-by":"publisher","DOI":"10.1517\/14656566.2015.1059424","article-title":"Pharmacological treatment for generalized anxiety disorder in adults: an update","volume":"16","author":"Reinhold","year":"2015","journal-title":"Expert Opin Pharmacotherapy"},{"key":"B89","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/0163-8343(91)90122-D","article-title":"Evidence-based benzodiazepine practice guidelines are needed","volume":"85","author":"Sigler","year":"2024","journal-title":"J Clin Psychiatry"},{"key":"B90","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2012.01.003","article-title":"Prevalence and trends of benzodiazepine use among Veterans Affairs patients with posttraumatic stress disorder 2003-2010","volume":"124","author":"Hawkins","year":"2012","journal-title":"Drug Alcohol Depend"},{"key":"B91","first-page":"A.256","article-title":"Characteristics of long-term alprazolam users","volume":"36","author":"Somer","year":"1989","journal-title":"Eur J Clin Pharmacol"},{"key":"B92","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1038\/clpt.1990.17","article-title":"Discontinuation symptoms among persistent alprazolam users","volume":"47","author":"Sellers","year":"1990","journal-title":"Clin Pharmacol Ther"},{"key":"B93","first-page":"19","article-title":"The use of low-dose intranasal midazolam to treat panic disorder: A pilot study","volume":"53","author":"Schweizer","year":"1992","journal-title":"J Clin Psychiatry"},{"key":"B94","doi-asserted-by":"publisher","DOI":"10.1002\/hup.470050206","article-title":"The effects of diazepam on cognitive processing","volume":"5","author":"Golombok","year":"1990","journal-title":"Hum Psychopharmacol: Clin Exp"},{"key":"B95","doi-asserted-by":"publisher","DOI":"10.1007\/BF01175729","article-title":"The effects of diazepam on anxiety-related cognition","volume":"15","author":"Golombok","year":"1991","journal-title":"Cognit Ther Res"},{"key":"B96","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpsychires.2020.08.014","article-title":"Trends in anxiety among adults in the United States 2008-2018: Rapid increases among young adults","volume":"130","author":"Goodwin","year":"2020","journal-title":"J\u00a0Psychiatr Res"},{"key":"B97","unstructured":"Designated Health Professional Shortage Area Statistics, First Quarter of Fiscal Year 2025 Designated HPSA Quarterly Summary\n          \n          \n          \n          2025"},{"key":"B98","doi-asserted-by":"publisher","DOI":"10.1016\/j.socscimed.2023.116358","article-title":"From prescribing dilemma to knowledge in practice: The ontological politics of benzodiazepines and Z-drugs","volume":"339","author":"Ceuterick","year":"2023","journal-title":"Soc Sci Med"}],"container-title":["Frontiers in Psychiatry"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fpsyt.2025.1569416\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,28]],"date-time":"2025-04-28T05:29:42Z","timestamp":1745818182000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fpsyt.2025.1569416\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,28]]},"references-count":98,"alternative-id":["10.3389\/fpsyt.2025.1569416"],"URL":"https:\/\/doi.org\/10.3389\/fpsyt.2025.1569416","relation":{},"ISSN":["1664-0640"],"issn-type":[{"value":"1664-0640","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,28]]},"article-number":"1569416"}}